Test Price
2,800 AED✅ Home Collection Available
ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ARMC4 للخلل الهدبي الأولي من النوع 23 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: يضمن هذا التحليل الجيني المتطور اكتشاف الطفرات في جين ARMC4 بدقة 99.9%، وفق أعلى معايير الجودة في التشخيص ما قبل الأعراض. بياناتك محمية بموجب المرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي.
Diagnostic Accuracy Guarantee: 99.9% diagnostic sensitivity for ARMC4 pathogenic variants via ISO 9001:2015 accredited NGS workflow (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid hospital‑grade home collection by DHA‑licensed phlebotomists with ISO‑certified cold‑chain transport (8 AM – 11 PM). VIP Mobile Phlebotomy available.
Clinical Guidance: Post‑test telephonic result interpretation with a multidisciplinary team (ENT, Pulmonology, Clinical Genetics).
Insurance Billing: Direct verification via WhatsApp at +971 54 548 8731.
Test Overview
This advanced Next‑Generation Sequencing (NGS) test screens the entire coding region and exon‑intron boundaries of the ARMC4 gene to detect single nucleotide variants, small insertions/deletions, and copy number variations associated with primary ciliary dyskinesia type 23 (PCD23). The assay replaces obsolete single‑gene methods, delivering comprehensive results in 3–4 weeks from whole blood, extracted DNA, or dried blood spot on an FTA card.
| Feature | Our Test (AGTC‑UAE) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Sensitivity | >99.9% (NGS with CNV detection and MLPA confirmation) | ~98% for point mutations; limited CNV detection |
| Methodology | Next‑Generation Sequencing (Illumina® platform) + bioinformatic pipeline aligned to DHA/MOHAP standards | Sanger sequencing of individual exons (time‑consuming iterative process) |
| Turnaround Speed | 3–4 weeks | 8–12 weeks (if full gene coverage required) |
| Sample Types Accepted | Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) | Whole Blood only |
| Price | 2800 AED (inclusive of genetic counselling) | Variable; often higher cumulative cost for full gene coverage |
Physician Insight & Safety Protocol
“As a senior clinical geneticist with over 20 years of experience in the UAE, I understand the anxiety a suspected primary ciliary dyskinesia diagnosis brings to families. This test is a powerful tool that clarifies the genetic basis of the condition, enabling tailored ENT, pulmonary, and fertility management. Please remember, genetic results must always be interpreted alongside clinical and radiological findings – never in isolation. I am here to guide you through your results with compassion and evidence‑based care.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
🛑 Medication Warning:
Do not discontinue any prescribed medication (e.g., mucolytics, bronchodilators, or prophylactic antibiotics) without consulting your managing physician. Stopping therapy abruptly can lead to acute respiratory deterioration.
⚠️ Safety Exclusion Criteria & Emergency Red Flags:
- Patients with acute febrile illness or haemodynamic instability – postpone blood draw until clinically stable.
- Inability to provide informed consent (use minor age‑appropriate assent per UAE CDS Law 2026; guardian consent mandatory).
- Known severe bleeding diathesis – discuss with laboratory physician prior to venipuncture.
🚨 Seek immediate emergency care if you experience:
- Sudden severe shortness of breath or cyanosis (bluish lips/fingertips).
- Sharp chest pain that worsens with breathing.
- High fever (>39°C) unresponsive to antipyretics.
Patient FAQ & Clinical Guidance
1. Why do I need this ARMC4 gene test and what does it tell my doctor?
Direct Answer: This test identifies pathogenic variants in the ARMC4 gene that cause primary ciliary dyskinesia type 23, confirming diagnosis and guiding personalised treatment plans for chronic lung, sinus, and fertility issues.
لماذا أحتاج هذا الاختبار؟ يحدد هذا الاختبار المتغيرات الجينية المسببة للمرض في جين ARMC4، مما يؤكد تشخيص الخلل الهدبي الأولي من النوع 23 ويوجه خطة علاجية فردية لمشاكل الرئة والجيوب الأنفية والخصوبة.
2. How accurate is the NGS test, and can I trust home collection?
Direct Answer: The test achieves over 99.9% diagnostic sensitivity for all ARMC4 mutations, and our DHA‑licensed phlebotomy team maintains strict cold‑chain certification to ensure sample integrity from your doorstep.
ما مدى دقة الفحص؟ تصل حساسية التشخيص إلى أكثر من 99.9% لجميع طفرات ARMC4، ويحافظ فريق سحب الدم المرخص من هيئة الصحة بدبي على سلسلة تبريد معتمدة لضمان سلامة العينة من منزلك.
3. What do I do if my test result is positive for a pathogenic variant?
Direct Answer: A positive result mandates immediate multidisciplinary consultation (ENT, pulmonology, genetics) to establish a proactive health surveillance plan and discuss familial implications, fully supported by our genetic counselling team.
ماذا أفعل إذا كانت نتيجتي إيجابية؟ تستدعي النتيجة الإيجابية استشارة فورية متعددة التخصصات (أنف وأذن وحنجرة، أمراض صدرية، ووراثة) لوضع خطة متابعة صحية استباقية ومناقشة الآثار العائلية، وبدعم كامل من فريق الاستشارات الوراثية.
Pre‑test Information:
A detailed clinical history of suspected primary ciliary dyskinesia (chronic wet cough, recurrent sinusitis, otitis media, situs inversus, male infertility) must be provided. A pre‑ genetic counselling session to draw a pedigree chart of affected family members is mandatory. No drug or supplement avoidance is required before specimen collection.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians